Obesity among individuals with serious mental illness.

A behavioral weight-loss intervention in persons with serious mental illness. N Engl J Med (2013) 5.52

Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomes. Am J Psychiatry (2014) 1.94

Pharmacological strategies to counteract antipsychotic-induced weight gain and metabolic adverse effects in schizophrenia: a systematic review and meta-analysis. Schizophr Bull (2014) 1.60

Health promotion in individuals with mental disorders: a cluster preference randomized controlled trial. BMC Public Health (2013) 1.44

Effectiveness and cost-effectiveness of lifestyle interventions on physical activity and eating habits in persons with severe mental disorders: a systematic review. Int J Behav Nutr Phys Act (2011) 1.08

Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One (2014) 1.02

The impact of obesity on health care costs among persons with schizophrenia. Gen Hosp Psychiatry (2008) 1.02

Utilization of primary care by veterans with psychiatric illness in the National Department of Veterans Affairs Health Care System. J Gen Intern Med (2008) 0.95

Wearable Devices and Smartphones for Activity Tracking Among People with Serious Mental Illness. Ment Health Phys Act (2016) 0.89

The prevalence of night eating syndrome and binge eating disorder among overweight and obese individuals with serious mental illness. Psychiatry Res (2010) 0.87

Predictors of mortality in patients with serious mental illness and co-occurring type 2 diabetes. Psychiatry Res (2010) 0.85

Double-blind, randomized, clinical trial of metformin as add-on treatment with clozapine in treatment of schizophrenia disorder. J Res Med Sci (2015) 0.85

Costs of implementing a behavioral weight-loss and lifestyle-change program for individuals with serious mental illnesses in community settings. Transl Behav Med (2015) 0.83

The effects of lifestyle interventions on (long-term) weight management, cardiometabolic risk and depressive symptoms in people with psychotic disorders: a meta-analysis. PLoS One (2014) 0.83

Body mass index and quality of life among outpatients with schizophrenia in Japan. BMC Psychiatry (2013) 0.82

The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review. Sleep Med (2011) 0.82

Pharmacological mechanisms underlying the association of antipsychotics with metabolic disorders. Curr Health Sci J (2013) 0.81

Improving Weight in People with Serious Mental Illness: The Effectiveness of Computerized Services with Peer Coaches. J Gen Intern Med (2017) 0.81

Body composition in patients with schizophrenia: Comparison with healthy controls. Ann Gen Psychiatry (2012) 0.81

Role of a psychiatric pharmacist in a Los Angeles "Skid-Row" safety-net clinic. J Urban Health (2011) 0.80

Lifestyle Intervention for People With Severe Obesity and Serious Mental Illness. Am J Prev Med (2015) 0.78

Barriers and facilitators of a healthy lifestyle among persons with serious and persistent mental illness: perspectives of community mental health providers. Community Ment Health J (2014) 0.78

Relief of cannabis withdrawal symptoms and cannabis quitting strategies in people with schizophrenia. Psychiatry Res (2013) 0.78

Perceptions of strategies for successful weight loss in persons with serious mental illness participating in a behavioral weight loss intervention: A qualitative study. Psychiatr Rehabil J (2016) 0.77

Attitudes toward metabolic adverse events among patients with schizophrenia in Japan. Neuropsychiatr Dis Treat (2016) 0.77

Changes in body weight, body composition and cardiovascular risk factors after long-term nutritional intervention in patients with severe mental illness: an observational study. BMC Psychiatry (2011) 0.76

A qualitative study exploring facilitators for improved health behaviors and health behavior programs: mental health service users' perspectives. ScientificWorldJournal (2014) 0.75

Patient Safety Events and Harms During Medical and Surgical Hospitalizations for Persons With Serious Mental Illness. Psychiatr Serv (2016) 0.75

Visceral obesity in normal-weight patients suffering from chronic schizophrenia. BMC Psychiatry (2014) 0.75

Anthropometric characteristics and the burden of altered nutritional status among neuropsychiatric patients at Zomba Mental Hospital in Zomba, Malawi. Malawi Med J (2015) 0.75

A cost analysis of implementing a behavioral weight loss intervention in community mental health settings: Results from the ACHIEVE trial. Obesity (Silver Spring) (2017) 0.75

Associations Between Gender and Obesity Among Adults with Mental Illnesses in a Community Health Screening Study. Community Ment Health J (2015) 0.75

A scoping review of weight bias by community pharmacists towards people with obesity and mental illness. Can Pharm J (Ott) (2016) 0.75

Are cardiometabolic and endocrine abnormalities linked to sleep difficulties in schizophrenia? A hypothesis driven review. Clin Psychopharmacol Neurosci (2012) 0.75

Predictors of Calf Arterial Compliance in Male Veterans With Psychiatric Diagnoses. Prim Care Companion CNS Disord (2016) 0.75

Antipsychotic drugs opposite to metabolic risk: neurotransmitters, neurohormonal and pharmacogenetic mechanisms underlying with weight gain and metabolic syndrome. Open Neurol J (2013) 0.75

Can anti-inflammatory medications improve symptoms and reduce mortality in schizophrenia? Curr Psychiatr (2016) 0.75

Patient, Provider, and System Factors Contributing to Patient Safety Events During Medical and Surgical Hospitalizations for Persons With Serious Mental Illness. J Nerv Ment Dis (2017) 0.75

Perforated appendicitis in patients with schizophrenia: a retrospective cohort study. BMJ Open (2017) 0.75

Association Between Cardiovascular Risk and Depressive Symptoms Among People With Serious Mental Illness. J Nerv Ment Dis (2017) 0.75

Femtosecond electronic response of atoms to ultra-intense X-rays. Nature (2010) 4.46

The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. N Engl J Med (1993) 4.34

Proximal impact of two first-grade preventive interventions on the early risk behaviors for later substance abuse, depression, and antisocial behavior. Am J Community Psychol (1999) 3.98

The effect of the level of aggression in the first grade classroom on the course and malleability of aggressive behavior into middle school. Dev Psychopathol (1998) 3.39

Gene expression profiling of cells, tissues, and developmental stages of the nematode C. elegans. Cold Spring Harb Symp Quant Biol (2003) 3.22

Comparison of the lay Diagnostic Interview Schedule and a standardized psychiatric diagnosis. Experience in eastern Baltimore. Arch Gen Psychiatry (1985) 3.18

The hemostatic defect produced by carbenicillin. N Engl J Med (1974) 2.99

An evaluation of the PCAT examination based on academic performance. Am J Pharm Educ (1977) 2.99

The intermediate endpoint effect in logistic and probit regression. Clin Trials (2007) 2.67

The CspA family in Escherichia coli: multiple gene duplication for stress adaptation. Mol Microbiol (1998) 2.50

Treatment and survival in breast cancer in the Eastern Region of England. Ann Oncol (2009) 2.45

Graft fixation in cruciate ligament reconstruction. Am J Sports Med (2001) 2.28

Sustained outcomes of a peer-taught family education program on mental illness. Acta Psychiatr Scand (2012) 2.06

Hamstring tendon grafts for reconstruction of the anterior cruciate ligament: biomechanical evaluation of the use of multiple strands and tensioning techniques. J Bone Joint Surg Am (1999) 1.98

Developmental epidemiologically based preventive trials: baseline modeling of early target behaviors and depressive symptoms. Am J Community Psychol (1991) 1.94

A randomized trial of assertive community treatment for homeless persons with severe mental illness. Arch Gen Psychiatry (1997) 1.85

Risk factors in schizophrenia. Season of birth, gender, and familial risk. Br J Psychiatry (1992) 1.81

Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease. J Clin Oncol (1995) 1.73

MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene (2012) 1.73

Heterogeneous growth and mental development of intrauterine growth-retarded infants during the first 3 years of life. Pediatrics (1984) 1.70

Deletion analysis of cspA of Escherichia coli: requirement of the AT-rich UP element for cspA transcription and the downstream box in the coding region for its cold shock induction. Mol Microbiol (1997) 1.66

Pulmonary veno-occlusive disease. Lancet (1966) 1.62

Time-resolved pump-probe experiments at the LCLS. Opt Express (2010) 1.61

Bone marrow necrosis. A study of seventy cases. Johns Hopkins Med J (1972) 1.57

A case study on the choice, interpretation and checking of multilevel models for longitudinal binary outcomes. Biostatistics (2001) 1.55

Socio-demographic inequalities in stage of cancer diagnosis: evidence from patients with female breast, lung, colon, rectal, prostate, renal, bladder, melanoma, ovarian and endometrial cancer. Ann Oncol (2012) 1.54

The effects of maximal resistance training on the strength and body composition of women athletes. Med Sci Sports (1974) 1.53

Study of the effects of ticarcillin on blood coagulation and platelet function. Antimicrob Agents Chemother (1975) 1.49

Signal amplification by rolling circle amplification on DNA microarrays. Nucleic Acids Res (2001) 1.49

Assembly of a chromosomal replication machine: two DNA polymerases, a clamp loader, and sliding clamps in one holoenzyme particle. I. Organization of the clamp loader. J Biol Chem (1995) 1.49

Pseudo acute abdomen following gastroscopy. Gastrointest Endosc (1967) 1.46

The role of the 5'-end untranslated region of the mRNA for CspA, the major cold-shock protein of Escherichia coli, in cold-shock adaptation. J Bacteriol (1996) 1.39

Defective platelet function following the administration of penicillin compounds. Blood (1976) 1.37

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone? Br J Cancer (2008) 1.35

Molecular biology and pharmacology of cloned opioid receptors. FASEB J (1995) 1.34

Morphological, biochemical, and functional changes in human platelets subjected to shear stress. J Lab Clin Med (1975) 1.33

Sustained activation of Ras/Raf/mitogen-activated protein kinase cascade by the tumor suppressor p53. Proc Natl Acad Sci U S A (2000) 1.32

Ultraintense x-ray induced ionization, dissociation, and frustrated absorption in molecular nitrogen. Phys Rev Lett (2010) 1.31

Assembly of a chromosomal replication machine: two DNA polymerases, a clamp loader, and sliding clamps in one holoenzyme particle. II. Intermediate complex between the clamp loader and its clamp. J Biol Chem (1995) 1.30

Anterior cruciate ligament graft fixation. Comparison of hamstring and patellar tendon grafts. Am J Sports Med (1994) 1.30

In vitro growth of normal and leukemic human bone marrow. J Natl Cancer Inst (1971) 1.27

Passive protective effect of egg-yolk antibodies against enterotoxigenic Escherichia coli K88+ infection in neonatal and early-weaned piglets. FEMS Immunol Med Microbiol (1999) 1.27

Hospital discharge instructions: comprehension and compliance among older adults. J Gen Intern Med (2014) 1.27

Nonlinear atomic response to intense ultrashort x rays. Phys Rev Lett (2011) 1.24

Physiological pathways regulating the activity of magnocellular neurosecretory cells. Prog Neurobiol (1999) 1.24

Photoscanning in diagnosis of carcinoma of the pancreas. Ann Intern Med (1966) 1.21

Evolving use of OKT3 monoclonal antibody for treatment of renal allograft rejection. Transplantation (1984) 1.20

Overexpression of kinase-associated phosphatase (KAP) in breast and prostate cancer and inhibition of the transformed phenotype by antisense KAP expression. Mol Cell Biol (2000) 1.19

Variation in advanced stage at diagnosis of lung and female breast cancer in an English region 2006-2009. Br J Cancer (2012) 1.19

Ulcerative proctitis: course and prognosis. Gastroenterology (1966) 1.18

The treatment of cryptogenic fibrosing alveolitis with immunosuppressant drugs. Q J Med (1971) 1.17

Characterization of the molecularly cloned murine alpha-globin transcription factor CP2. J Biol Chem (1993) 1.15

Assertive community treatment and case management for schizophrenia. Schizophr Bull (1995) 1.15

Adolescents engaging in unhealthy weight control behaviors: are they at risk for other health-compromising behaviors? Am J Public Health (1998) 1.15

Maternal employment during the early postpartum period: effects on initiation and continuation of breast-feeding. Pediatrics (1991) 1.14

Virus-specific delayed-type hypersensitivity (DTH). Cells mediating lymphocytic choriomeningitis virus-specific DTH reaction in mice. J Immunol (1990) 1.12

Glial regulation of neuronal function: from synapse to systems physiology. J Neuroendocrinol (2012) 1.11

Responses of magnocellular neurons to osmotic stimulation involves coactivation of excitatory and inhibitory input: an experimental and theoretical analysis. J Neurosci (2001) 1.10

Effect of the relative position of the UGA codon to the unique secondary structure in the fdhF mRNA on its decoding by selenocysteinyl tRNA in Escherichia coli. J Biol Chem (1993) 1.10

Early predictors of age at first use of alcohol, marijuana, and cigarettes. Drug Alcohol Depend (1982) 1.10

Nitric oxide synthase in spinal cord central sensitization following intradermal injection of capsaicin. Pain (2001) 1.09

A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatr Serv (2000) 1.09

Physiological profiles of women distance runners. Med Sci Sports (1974) 1.09

The Pathways study: a model for lowering the fat in school meals. Am J Clin Nutr (1999) 1.08

SJL/J mice are highly susceptible to infection by mouse adenovirus type 1. J Virol (2001) 1.08

A comparison of two doses of tamoxifen (Nolvadex) in postmenopausal women with advanced breast cancer: 10 mg bd versus 20 mg bd. Br J Cancer (1984) 1.08

Radiological staging in breast cancer: which asymptomatic patients to image and how. Br J Cancer (2009) 1.08

The role of family factors, physical abuse, and sexual victimization experiences in high-risk youths' alcohol and other drug use and delinquency: a longitudinal model. Violence Vict (1992) 1.08

Mutations in BMPR-IB and BMP-15 genes are associated with litter size in Small Tailed Han sheep (Ovis aries). J Anim Sci (2006) 1.08

Rheological properties of fibrin clots. Effects of fibrinogen concentration, Factor XIII deficiency, and Factor XIII inhibition. J Lab Clin Med (1975) 1.07

A comparison of two radiotherapy regimens for the treatment of symptoms from advanced bladder cancer. Clin Oncol (R Coll Radiol) (1994) 1.07

A conformational switch in the ligand-binding domain regulates the dependence of the glucocorticoid receptor on Hsp90. J Mol Biol (2007) 1.07

Computerized radiographic analysis of osteoporosis: preliminary evaluation. Radiology (1993) 1.06

Outcomes of the peer-taught 12-week family-to-family education program for severe mental illness. Acta Psychiatr Scand (2004) 1.05

Lymphoma of the colon simulating ulcerative colitis. Report of four cases. Am J Dig Dis (1968) 1.04

Do contact precautions cause depression? A two-year study at a tertiary care medical centre. J Hosp Infect (2011) 1.03

Dose range study of pharmacokinetics, safety, and preliminary antiviral activity of emtricitabine in adults with hepatitis B virus infection. Antimicrob Agents Chemother (2002) 1.03

Mutation analysis and the correlation between genotype and phenotype of Arg778Leu mutation in chinese patients with Wilson disease. Arch Neurol (2001) 1.02

Lethal outcome of uterine infection in pregnant but not in nonpregnant rats and increased death rate with inhibition of nitric oxide. Am J Reprod Immunol (1997) 1.01

Novel mutations and a mutational hotspot in the MODY3 gene. Diabetes (1997) 1.01

Myocardial oxidative stress contributes to transgenic β₂-adrenoceptor activation-induced cardiomyopathy and heart failure. Br J Pharmacol (2011) 1.00

The epidemiology of psychiatrist-ascertained depression and DSM-III depressive disorders. Results from the Eastern Baltimore Mental Health Survey Clinical Reappraisal. Psychol Med (1992) 1.00

Cyclic urinary leukopoietic activity in gray collie dogs. Science (1971) 1.00

Frequency-dependent effect of nitric oxide donor nitroglycerin on bone. J Bone Miner Res (2000) 1.00

Detection of substance use disorders among psychiatric inpatients. J Nerv Ment Dis (1996) 1.00

Influence of cephalosporin antibiotics on blood coagulation and platelet function. Antimicrob Agents Chemother (1976) 1.00

Auger electron angular distribution of double core-hole states in the molecular reference frame. Phys Rev Lett (2010) 0.99

Ethnic differences in erythrocyte catechol-O-methyltransferase activity in black and white Americans. J Pharmacol Exp Ther (1994) 0.99

Treatment of lupoid hepatitis with azathioprine. Cleve Clin Q (1967) 0.98

Unveiling and driving hidden resonances with high-fluence, high-intensity x-ray pulses. Phys Rev Lett (2011) 0.98

Social adaptation to first grade and teenage drug, alcohol and cigarette use. J Sch Health (1982) 0.96

Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China. Int J STD AIDS (2009) 0.95

Predictors of functional outcomes after arthroscopic partial meniscectomy. J Rheumatol (1992) 0.94

Hepatic arteriography. Radiology (1968) 0.94

CD30 signals integrate expression of cytotoxic effector molecules, lymphocyte trafficking signals, and signals for proliferation and apoptosis. J Immunol (2000) 0.94

Sequence polymorphism in the mtDNA HV1 region in Japanese and Chinese. Leg Med (Tokyo) (1999) 0.94

The effects of an anabolic steroid on the strength, body composition, and endurance of college males when accompanied by a weight training program. Med Sci Sports (1973) 0.94

Time and cost analysis of a computer-assisted telephone interview system to collect dietary recalls. Am J Epidemiol (1992) 0.94

Azathioprine therapy for inflammatory bowel disease. A preliminary report. Am J Gastroenterol (1970) 0.93

Complete growth inhibition of Escherichia coli by ribosome trapping with truncated cspA mRNA at low temperature. Genes Cells (1996) 0.93